Clinical Trial

Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease

Study acronym: STOP-COPD
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The STOP-COPD trial is a randomized, patient-blinded, prehospital clinical trial designed to evaluate the effect of titrated oxygen therapy compared to standard oxygen treatment in patients with suspected acute exacerbation of chronic obstructive pulmonary disease (AECOPD) treated with inhaled bronchodilators. The primary objective is to determine whether a titrated oxygen strategy targeting SpO₂ 88-92% can reduce 30-day mortality compared to the current standard practice using 100% compressed oxygen as a nebulizer driver.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-01-19; most recent amendment 2025-06-08.
Status change: Not Yet Recruiting → Recruiting 2025-06-08
Trial Details
NCT Number NCT05703919
Lead Sponsor Central Denmark Region
Conditions COPD Exacerbation, COPD Exacerbation Acute
Enrollment 1,888 participants
Start Date 2025-06-02
Primary Completion 2027-05-31 (estimated)
Study Completion 2028-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-10